Protease-Activated Receptor-2 Activation Induces Acute Lung Inflammation by Neuropeptide-Dependent Mechanisms 1

Protease-activated receptors (PARs) and tachykinin-immunoreactive fibers are located in the lung as sentries to respond to a variety of pathological stimuli. The effects of PAR activation on the lung have not been adequately studied. We report on the effects of instilling PAR-activating peptides (PAR-APs, including PAR1-, PAR2-, and PAR4-AP) into the lungs of ventilated or spontaneously breathing mice. PAR2-AP, but not PAR1-AP or PAR4-AP, caused a sharp increase in lung endothelial and epithelial permeability to protein, extravascular lung water, and airway tone. No responses to PAR2-AP were detected in PAR2 knockout mice. In bronchoalveolar lavage, PAR2 activation caused 8- and 5-fold increase in MIP-2 and substance P levels, respectively, and a 12-fold increase in the number of neutrophils. Ablation of sensory neurons (by capsaicin) markedly decreased the PAR2-mediated airway constriction, and virtually abolished PAR2-mediated pulmonary inflammation and edema, as did blockade of NK1 or NK2 receptors. Thus, PAR2 activation in the lung induces airway constriction, lung inflammation, and protein-rich pulmonary edema. These effects were either partly or completely neuropeptide dependent, suggesting that PAR2 can cause lung inflammation by a neurogenic mechanism.

[1]  J. Olerud,et al.  Neural regulation of endothelial cell-mediated inflammation. , 2008, The journal of investigative dermatology. Symposium proceedings.

[2]  C. Page,et al.  Effects of inhaled thrombin receptor agonists in mice , 2004, British journal of pharmacology.

[3]  K. Bacon,et al.  Cockroach allergen extract stimulates protease-activated receptor-2 (PAR-2) expressed in mouse lung fibroblast , 2004, Inflammation Research.

[4]  C. Bai,et al.  The role of aquaporin-1 (AQP1) expression in a murine model of lipopolysaccharide-induced acute lung injury , 2004, Respiratory Physiology & Neurobiology.

[5]  M. Hollenberg,et al.  Agonists of proteinase‐activated receptor‐2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3‐D collagen lattices , 2004, Journal of leukocyte biology.

[6]  A. Lentsch,et al.  Involvement of the neuropeptide substance P in lung inflammation induced by hepatic ischemia/reperfusion , 2004, Inflammation Research.

[7]  C. Goss,et al.  Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury. , 2004, The Journal of thoracic and cardiovascular surgery.

[8]  N. Mackman,et al.  Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. , 2004, Blood.

[9]  M. Matthay,et al.  DIRECT VISUAL INSTILLATION AS A METHOD FOR EFFICIENT DELIVERY OF FLUID INTO THE DISTAL AIRSPACES OF ANESTHETIZED MICE , 2004, Experimental lung research.

[10]  D. Grundy,et al.  Stimulation of proteinase‐activated receptor 2 excites jejunal afferent nerves in anaesthetised rats , 2003, The Journal of physiology.

[11]  M. D'Andrea,et al.  Proteinase-activated receptors: novel signals for peripheral nerves , 2003, Trends in Neurosciences.

[12]  M. Carr,et al.  INVITED REVIEW SERIES: CELLS OF THE LUNG Bronchopulmonary afferent nerves , 2003 .

[13]  J. Fontan,et al.  Bone marrow transplantation reveals an essential synergy between neuronal and hemopoietic cell neurokinin production in pulmonary inflammation. , 2003, The Journal of clinical investigation.

[14]  S. Klarenbach,et al.  Differential Actions of PAR2 and PAR1 in Stimulating Human Endothelial Cell Exocytosis and Permeability: The Role of Rho-GTPases , 2003, Circulation research.

[15]  P. Noble,et al.  CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. , 2002, The American journal of pathology.

[16]  V. Meineke,et al.  Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ: Possible relevance to human fibrotic disorders , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. D'Andrea,et al.  Characterization of Thrombin-Induced Leukocyte Rolling and Adherence: A Potential Proinflammatory Role for Proteinase-Activated Receptor-41 , 2002, The Journal of Immunology.

[18]  S. Coughlin,et al.  Genetic Evidence That Protease-activated Receptors Mediate Factor Xa Signaling in Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[19]  P. Thompson,et al.  Activation of Protease-Activated Receptor (PAR)-1, PAR-2, and PAR-4 Stimulates IL-6, IL-8, and Prostaglandin E2 Release from Human Respiratory Epithelial Cells1 , 2002, The Journal of Immunology.

[20]  E. Mazzon,et al.  Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation , 2002, British journal of pharmacology.

[21]  P. Poronnik,et al.  Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[22]  P. Thompson,et al.  Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. , 2001, The Journal of allergy and clinical immunology.

[23]  N. Martinet,et al.  Expression and function of proteinase-activated receptor 2 in human bronchial smooth muscle. , 2001, American journal of respiratory and critical care medicine.

[24]  W. Ruf,et al.  Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Knight,et al.  Role of PGE2 in protease‐activated receptor‐1, −2 and −4 mediated relaxation in the mouse isolated trachea , 2001, British journal of pharmacology.

[26]  D. Bernstein,et al.  Delayed Onset of Inflammation in Protease-Activated Receptor-2-Deficient Mice1 , 2000, The Journal of Immunology.

[27]  Jennifer L. Harris,et al.  Cellular Localization of Membrane-type Serine Protease 1 and Identification of Protease-activated Receptor-2 and Single-chain Urokinase-type Plasminogen Activator as Substrates* , 2000, The Journal of Biological Chemistry.

[28]  G. Joos,et al.  Role of tachykinins in asthma , 2000, Allergy.

[29]  A. Janecka,et al.  Comparison of antagonistic properties of substance P analogs, spantide I, II and III, on evoked tongue jerks in rats. , 2000, Endocrine regulations.

[30]  J. Wallace,et al.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism , 2000, Nature Medicine.

[31]  N. Vergnolle Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. , 1999, Journal of immunology.

[32]  J. Pittet,et al.  Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. , 1999, American journal of respiratory and critical care medicine.

[33]  M. Carr,et al.  A protective role for protease-activated receptors in the airways , 1999, Nature.

[34]  J. Olerud,et al.  VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P. , 1999, Journal of immunology.

[35]  D. Leduc,et al.  Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs. , 1998, Journal of immunology.

[36]  Scott R. Presnell,et al.  Cloning and characterization of human protease-activated receptor 4. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. M. Baker,et al.  Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[38]  C. Verastegui,et al.  Presence and distribution of 5HT-, VIP-, NPY-, and SP-immunoreactive structures in adult mouse lung. , 1997, Histology and histopathology.

[39]  S. Coughlin,et al.  Protease-activated receptor 3 is a second thrombin receptor in humans , 1997, Nature.

[40]  M. Macey,et al.  Proteinase-activated receptor-2: expression by human neutrophils. , 1997, Journal of cell science.

[41]  T. Tedder,et al.  Neutrophil margination, sequestration, and emigration in the lungs of L-selectin-deficient mice. , 1997, The Journal of clinical investigation.

[42]  H. Folkesson,et al.  Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. , 1995, The Journal of clinical investigation.

[43]  C. Wahlestedt,et al.  Molecular cloning of a potential proteinase activated receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Mcelroy,et al.  Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor. , 1992, Journal of medicinal chemistry.

[45]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[46]  T. Hökfelt,et al.  Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man , 2004, Cell and Tissue Research.

[47]  L. Fabbri,et al.  Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways. , 2000, American journal of respiratory and critical care medicine.